News

Reimbursement authority NICE has backed routine NHS use of Vertex's once-daily triple therapy Alyftrek ...
My Expert Midwife, a maternal health brand founded by practicing midwives, has secured £1.6m in follow-on funding to support ...
Removing incorrect penicillin allergy labels on GP records could combat antibiotic resistance and save lives, an NIHR-funded ...
Experts have issued a cautionary note that around half a million people using weight loss injections could potentially invalidate their travel insurance this summer. Medications such as Mounjaro and ...
Maternal health brand My Expert Midwife raises £1.6m in follow-on funding led by Pembroke VCT to fuel e-commerce, product ...
A scheme which will see solar panels placed on the roofs of hundreds of schools and hospitals could be expanded to include ...
Hundreds of children and adults in England with rare forms of cystic fibrosis will now be able to access a new triple-combinatio ...
Parents in Milton Keynes have been alerted to the risk of measles, following reports this weekend that a child has sadly died of the disease in England.
Ovarian cancer symptoms can be vague and ill-defined, leading to the creation of a catch-all acronym - BEAT. Dr. Thompson is ...
The National Institute for Health and Care Excellence (Nice) has approved Alyftrek, a new modulator therapy for cystic fibrosis, hailed as "life-changing" by health experts.